IL1B and diabetic neuropathy: In terms of neuropathic pain, systemic administration of GAS relieved hyperalgesia and allodynia in models of painful diabetic neuropathy and chemotherapy-induced neuropathic pain via inhibition of DRG neuron hyperexcitability, inhibition of microglial activation, or reduction of TNF-α and IL-1β [16, 18].